Table 3.

Recurrences and functional outcomes for patients with unilateral and bilateral masses

	Unilateral Adrenal Mass (N = 45)		Bilateral Adrenal Mass (N = 21)
	Partial Adrenalectomy (N = 22)	Total Adrenalectomy (N = 23)	Partial Adrenalectomy (N = 13)	Total Adrenalectomy (N = 8)
Evaluation of Patients with Recurrences
Patients with at least one additional pheo: N, (%)	7(32)	6 (26)	4 (31)	0 (0)
Years to first additional pheo: mean, (range)	5.6 (0.2–15.0)	5.4 (0.9–14.3)	13.2 (0.4–34.6)	–
Patients with multiple additional pheo: N, (%)	3 (14)	4 (17)	0 (0)	0
Evaluation of Total Number of Recurrences
Total ipsilateral recurrences: N, (%)	3 (15)	1 (4)	3 (38)	0 (0)
Years to ipsilateral recurrence: mean (range)	3.8 (0.4–8.0)	3.3 (3.3–3.3)	13.2 (0.4–34.6)	–
Total contralateral pheo: N, (%)	6 (23)	6 (26)	–	–
Years to contralateral pheo: mean (range)	6.0 (0.2–15.0)	6.1 (1.2–12.7)	–	–
Total extra adrenal pheo: N (%)	2 (9)	4 (17)	0 (0)	0
Years to extra adrenal pheo: mean (range)	7.2 (0.4–8.5)	4.7 (0.9–14.3)	–	–
Functional Outcomes
Require steroid replacement: N, (%)	0 (0)	2 (8)	1 (13)	8 (100)